The store will not work correctly when cookies are disabled.
(3R)-3-Amino-4-oxo-4-[3-(trifluoromethoxy)anilino]butanoic acid
ID: ALA4755686
PubChem CID: 155289363
Max Phase: Preclinical
Molecular Formula: C11H11F3N2O4
Molecular Weight: 292.21
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: N[C@H](CC(=O)O)C(=O)Nc1cccc(OC(F)(F)F)c1
Standard InChI: InChI=1S/C11H11F3N2O4/c12-11(13,14)20-7-3-1-2-6(4-7)16-10(19)8(15)5-9(17)18/h1-4,8H,5,15H2,(H,16,19)(H,17,18)/t8-/m1/s1
Standard InChI Key: LHAPJSHUQJWWEP-MRVPVSSYSA-N
Molfile:
RDKit 2D
20 20 0 0 0 0 0 0 0 0999 V2000
28.6127 -4.6926 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.6115 -5.5122 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.3196 -5.9211 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.0292 -5.5117 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.0264 -4.6890 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.3178 -4.2838 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.9035 -5.9202 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
27.1961 -5.5110 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.4881 -5.9191 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
27.1967 -4.6938 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
26.4844 -5.1013 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
30.7376 -5.9192 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
31.4446 -5.5095 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.1530 -5.9169 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.4434 -4.6923 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
32.8601 -5.5072 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
32.1543 -6.7341 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.4472 -7.1438 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.4485 -7.9610 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
30.7389 -6.7364 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
2 7 1 0
7 8 1 0
8 9 1 0
8 10 1 0
8 11 1 0
4 12 1 0
12 13 1 0
13 14 1 0
13 15 2 0
14 16 1 6
14 17 1 0
17 18 1 0
18 19 1 0
18 20 2 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 292.21 | Molecular Weight (Monoisotopic): 292.0671 | AlogP: 1.33 | #Rotatable Bonds: 5 |
Polar Surface Area: 101.65 | Molecular Species: ACID | HBA: 4 | HBD: 3 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 3.15 | CX Basic pKa: 8.37 | CX LogP: -0.62 | CX LogD: -0.66 |
Aromatic Rings: 1 | Heavy Atoms: 20 | QED Weighted: 0.76 | Np Likeness Score: -0.85 |
References
1. Yamada Y,Takashima H,Walmsley DL,Ushiyama F,Matsuda Y,Kanazawa H,Yamaguchi-Sasaki T,Tanaka-Yamamoto N,Yamagishi J,Kurimoto-Tsuruta R,Ogata Y,Ohtake N,Angove H,Baker L,Harris R,Macias A,Robertson A,Surgenor A,Watanabe H,Nakano K,Mima M,Iwamoto K,Okada A,Takata I,Hitaka K,Tanaka A,Fujita K,Sugiyama H,Hubbard RE. (2020) Fragment-Based Discovery of Novel Non-Hydroxamate LpxC Inhibitors with Antibacterial Activity., 63 (23): [PMID:33210531] [10.1021/acs.jmedchem.0c01215] |